New diabetes drug MK-2828 passes early safety check

NCT ID NCT07089784

Completed Symptom relief Sponsor: Merck Sharp & Dohme LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage study tested a new medicine called MK-2828 in 46 adults with type 2 diabetes. The main goal was to see if the drug is safe and well-tolerated. Researchers also measured how the drug moves through the body and its effect on a marker of inflammation (hsCRP). This is a first step to see if MK-2828 might help control diabetes in the future.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES MELLITUS, TYPE 2

Contacts and locations

Locations

AMR Clinical ( Site 0003)

Knoxville, Tennessee, 37920, United States
AMR Lexington ( Site 0012)

Lexington, Kentucky, 40509, United States
Advanced Pharma CR, LLC ( Site 0001)

Miami, Florida, 33147, United States
Alliance for Multispecialty Research, LLC ( Site 0013)

Kansas City, Missouri, 64114, United States
Bio-Kinetic Clinical Applications, LLC dba QPS-MO ( Site 0009)

Springfield, Missouri, 65802, United States
California Clinical Trials Medical Group managed by PAREXEL ( Site 0008)

Glendale, California, 91206, United States
ICON Early Phase Services ( Site 0006)

San Antonio, Texas, 78209, United States
Jacksonville Center for Clinical Research ( Site 0002)

Jacksonville, Florida, 32216, United States
ProSciento Inc. ( Site 0004)

Chula Vista, California, 91911, United States
QPS Miami Research Associates ( Site 0005)

South Miami, Florida, 33143, United States
Velocity Clinical Research, Hallandale Beach ( Site 0010)

Hallandale, Florida, 33009, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.